Charles Cobb Jr.
14 December 2001
Washington, DC — The Global Partnership to Eliminate River blindness announced Friday that US$39m has been pledged by donors to wipe out Onchocerciasis, more commonly known as River Blindness, in Africa by 2010. The disease causes blindness, skin lesions, disfigurement and almost unbearable itching.
The news comes amid celebration that the first phase of the campaign has been so successful; World Heath Organisation officials say River Blindness has almost been eliminated in West Africa; some 1.5m people in the region who were once infected with the disease no longer have any trace of it.
The disease is caused by a parasitic worm, "onchocerca volvulus." This worm grows from a parasite that is introduced into humans by the bite of a blackfly. The adult worm, over its fourteen-year life span, produces millions of microscopic parasites - "microfilariae." These infant parasites spread throughout the body causing the disease.
The flies need fast, running water to breed and in 1972, two French scientists proposed attacking the blackfly when it seemed most vulnerable: during its larval stage, when it clung to sticks and rocks in the rivers. If blackflies could be controlled for at least 14 years, they reasoned - the time an adult worm lives in the human body - then theoretically the parasite colony in humans would die out.
In 1972, they convinced Robert McNamara, then President of the World Bank, that this would work. McNamara was traveling in West Africa, to see the effects of the severe drought that was battering the Sahel. Donald B. Easum, then U.S. Ambassador to Upper Volta (since renamed Burkina Faso) recalls that while McNamara was visiting the capital, Ouagadougou, he asked to visit Bobo Dioulasso in the southwest to talk with ORSTOM (Institut Français de Recherche Scientifique pour le Dèveloppement en Coopération), the French tropical medicine research organization.
"While there inspecting drought conditions," says Easum, "he was struck, as was his wife, by the tremendous number of people who were blind, especially farmers who in their villages were being led around the place on a stick by a child.They were very moved by that."
"Of course, he may have gone to Bobo Dioulasso with something of this already in his mind. After all why would he go to see these French technicians if it was solely the drought that he was interested in? He may have been told about blindness before he got there, but he certainly saw a lot of blindness there when they were going around the countryside."
Easum describes McNamara as "very much taken" with the research aimed at controlling the blackfly. "And when he got back to Washington he called a meeting in Paris to meet with possible interested organizations. In 1974, McNamara announced that the World Bank would embark on a major program to attack this disease by means of spraying river valleys where the fly was breeding."
In its first phase, the Onchocerciasis Control Program (APOC) targeted West Africa, using a two-pronged combination of spraying and treatment with the drug "Ivermectin" provided free by pharmaceutical company, Merck and administered once a year to the people living in the affected areas.
Today, "except for one or two pockets where the disease remains," said a World Bank spokesperson, it been has almost completely eliminated in 11 West African nations.
18m children born in the target area during the programme now "face no risk of the disease," according to a World Bank statement. Forty million people in the 11-nation area of operation are currently protected and 25 million hectares of arable land has been made safe for farming and settlement.
The partnership fighting River Blindness includes representatives from some 30 African nations, Merck which, between 1987 and the end of 1996, donated more than 65m doses of the drug, a dozen NGOs and agencies such as the World Bank, World Health Organization (WHO), United Nations Development Program (UNDP) and the Food and Agriculture Organization (FAO). They have been meeting all week at World Bank Headquarters.
The newly pledged US$39m is for the second phase of APOC and will be targeted at central, eastern and southern Africa. The Partnership believes it can replicate its success in West Africa throughout the sub-Saharan region, where the disease remains one of the major causes of blindness. Out of 120m people worldwide who are at risk of onchocerciasis, 96% are in Africa, the remainder in Yemen and some Latin American countries.
Read comments. Write your own.
Copyright © 2001 allAfrica.com. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.
AllAfrica aggregates and indexes content from over 125 African news organizations, plus more than 200 other sources, who are responsible for their own reporting and views. Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica.
NOMINATION IS OPEN UNTIL APRIL 2008 International Organizations, NGOs and Individuals Compete for AGFUND Prize on Prevention of Visual Impairment
The Arab Gulf Programme for United Nations Development Organizations (AGFUND) declares commencement of receiving nominations for AGFUND International Prize for Pioneering Development Projects. AGFUND invites UN, international and regional non-governmental organizations, national NGOs, universities and research centers all over the world to submit their nominations for the prize three categories. The prize subject for the year 2008 focuses on “Prevention of Visual Impairment”.
1. FIRST CATEGORY PRIZE: Subject: The international organizations' role in supporting the developing countries' national policies and programs to control the main causing diseases of visual impairment” for projects implemented by UN, international or regional organizations 2. SECOND CATEGORY PRIZE: Subject: “NGOs efforts in the prevention of visual impairment and rehabilitation of the blind people” for projects implemented by non-governmental organizations. 3. THIRD CATEGORY PRIZE: Subject: “Individual-led initiatives to develop the blind's capabilities and invest their skills” for projects initiated, sponsored and/or implemented by individuals. Nomination for AGFUND Prize may be mailed to AGFUND’s Communications Department & Prize Secretariat P. O. Box 18371 Riyadh 11415, Kingdom of Saudi Arabia or at email: Prize@agfund.org. AGFUND's website www.agfund.org may also be visited for further information and getting the nomination form. Nominations for the prize are accepted until 30 April 2008.
The value of AGFUND international prize amounts to US $ 300,000 distributed among the three categories. Membership of the Prize Committee comprises prominent international figures representing geographical world regions.
Evaluation of the projects nominated for the prize is conducted with neutrality and high transparency by referees selected every year in accordance with the expertise and specialties that suit the prize subjects.
Since its launch in 1999, twenty-five projects implemented by Un and international non-governmental organizations, national NGOs and individuals have won the prize. More than fifty developing countries in Asia, Africa, Latin America and Eastern Europe benefited from AGFUND Prize.